IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

TRV GP IV, LLC

Q2 2020 Holdings

Filed 2020-08-07 | 4 holdings | $217.1K | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Pliant Therapeutics, Inc.(PLRX)COM729139105$69.2K2,132,86731.9%
Magenta Therapeutics, Inc.COM55910K108$60.1K8,008,20427.7%
Revolution Medicines, Inc.(RVMD)COM76155X100$44.8K1,419,90020.7%
Fulcrum Therapeutics, Inc.(FULC)COM359616109$42.9K2,343,15419.7%